Relmada Therapeutics shares owned by Hexagon Capital Partners
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Hexagon Capital Partners
from 13F filings
Historical chart of Hexagon Capital Partners investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Hexagon Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Hexagon Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $19k | 4.0k | 4.65 |
| 2023-12-31 | $17k | 4.0k | 4.14 |
| 2023-09-30 | $12k | 4.0k | 3.00 |
| 2023-06-30 | $9.8k | 4.0k | 2.46 |
| 2023-03-31 | $3.6k | 1.6k | 2.26 |
| 2022-12-31 | $5.6k | 1.6k | 3.49 |
| 2022-09-30 | $59k | 1.6k | 36.88 |
| 2022-06-30 | $30k | 1.6k | 18.75 |
| 2022-03-31 | $43k | 1.6k | 26.88 |
| 2021-12-31 | $36k | 1.6k | 22.50 |
| 2021-09-30 | $42k | 1.6k | 26.25 |
| 2021-06-30 | $51k | 1.6k | 31.88 |
| 2021-03-31 | $56k | 1.6k | 35.00 |
| 2020-12-31 | $51k | 1.6k | 31.88 |
| 2020-09-30 | $47k | 1.6k | 29.38 |